Name of the speaker: Germano DiSciascio I have the following potential conflicts of interest to report: Consulting Employment in industry Stockholder of.
HPS2-THRIVE: Randomized placebo-controlled trial of ER niacin and laropiprant in 25,673 patients with pre-existing cardiovascular disease. Jane Armitage.
RETRAINING OBSTRUCTIVE PULMONARY DISEASE SUBJECTS: From theory to practice Alain VARRAY Diplôme Européen Universitaire en Activités Physiques Adaptées.
